Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2017

  • ID: 4394486
  • Report
  • 163 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • 3DT Holdings, LLC
  • C. R. Bard Inc
  • EnteroMedics Inc
  • Mayo Clinic US
  • Sensate LLC
  • Surefire Medical Inc
  • MORE
Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Bariatric Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bariatric Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Bariatric Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bariatric Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bariatric Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3DT Holdings, LLC
  • C. R. Bard Inc
  • EnteroMedics Inc
  • Mayo Clinic US
  • Sensate LLC
  • Surefire Medical Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 Bariatric Surgery Devices Overview
3 Products under Development
3.1 Bariatric Surgery Devices - Pipeline Products by Stage of Development
3.2 Bariatric Surgery Devices - Pipeline Products by Segment
3.3 Bariatric Surgery Devices - Pipeline Products by Territory
3.4 Bariatric Surgery Devices - Pipeline Products by Regulatory Path
3.5 Bariatric Surgery Devices - Pipeline Products by Estimated Approval Date
3.6 Bariatric Surgery Devices - Ongoing Clinical Trials
4 Bariatric Surgery Devices - Pipeline Products under Development by Companies
4.1 Bariatric Surgery Devices Companies - Pipeline Products by Stage of Development
4.2 Bariatric Surgery Devices - Pipeline Products by Stage of Development
5 Bariatric Surgery Devices Companies and Product Overview
5.1 3DT Holdings, LLC Company Overview
5.1.1 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Allurion Technologies, Inc. Company Overview
5.2.1 Allurion Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Apollo Endosurgery Inc Company Overview
5.3.1 Apollo Endosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Applied Medical Resources Corporation Company Overview
5.4.1 Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.5 BAROnova, Inc. Company Overview
5.5.1 BAROnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 BFKW, LLC Company Overview
5.6.1 BFKW, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.7 Boston Scientific Corp Company Overview
5.7.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.8 C. R. Bard Inc Company Overview
5.8.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Columbia University Company Overview
5.9.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
5.10 Crospon Ltd Company Overview
5.10.1 Crospon Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.11 EndoRetics Inc. Company Overview
5.11.1 EndoRetics Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.12 EndoVx Inc Company Overview
5.12.1 EndoVx Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 EnteroMedics Inc Company Overview
5.13.1 EnteroMedics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Gelesis Inc Company Overview
5.14.1 Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 GI Dynamics Inc Company Overview
5.15.1 GI Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Hebrew University of Jerusalem Company Overview
5.16.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
5.17 Innovia LLC Company Overview
5.17.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.18 John Hopkins University Company Overview
5.18.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.19 Mayo Clinic US Company Overview
5.19.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
5.20 Medi-Globe GmbH Company Overview
5.20.1 Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.21 MetaModix, Inc Company Overview
5.21.1 MetaModix, Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Mmtc, Inc. Company Overview
5.22.1 Mmtc, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.23 National University of Singapore Company Overview
5.23.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
5.24 Precision Medical Devices, Inc. Company Overview
5.24.1 Precision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.25 Satiety Inc Company Overview
5.25.1 Satiety Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 Sensate LLC Company Overview
5.26.1 Sensate LLC Pipeline Products & Ongoing Clinical Trials Overview
5.27 Silhouette Medical, Inc. Company Overview
5.27.1 Silhouette Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.28 SLIMEDICS LTD Company Overview
5.28.1 SLIMEDICS LTD Pipeline Products & Ongoing Clinical Trials Overview
5.29 Spatz FGIA, Inc Company Overview
5.29.1 Spatz FGIA, Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 Standard Bariatrics, Inc. Company Overview
5.30.1 Standard Bariatrics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.31 Surefire Medical Inc Company Overview
5.31.1 Surefire Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 SynerZ Medical, Inc. Company Overview
5.32.1 SynerZ Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.33 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview
5.33.1 The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview
5.34 TransEnterix, Inc. Company Overview
5.34.1 TransEnterix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.35 Tulip Medical Ltd. Company Overview
5.35.1 Tulip Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.36 UAS LifeSciences LLC Company Overview
5.36.1 UAS LifeSciences LLC Pipeline Products & Ongoing Clinical Trials Overview
5.37 University of Florida Company Overview
5.37.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.38 University of Miami Company Overview
5.38.1 University of Miami Pipeline Products & Ongoing Clinical Trials Overview
5.39 ValenTx, Inc. Company Overview
5.39.1 ValenTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.40 Vancive Medical Technologies Company Overview
5.40.1 Vancive Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.41 Vibrynt, Inc. Company Overview
5.41.1 Vibrynt, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6 Bariatric Surgery Devices- Recent Developments
6.1 Aug 31, 2017: Apollo Endosurgery Announces 20-year LAP-BAND Outcomes Data Presented at 22nd IFSO World Congress in London
6.2 Aug 30, 2017: Apollo Endosurgery Announces CE Mark Approval for the ORBERA365 Managed Weight Loss System, Expanding the Indwell Period from 6 Months to 12 Months with the Gastric Balloon Category Leader
6.3 Aug 23, 2017: GI Dynamics Appoints Juliet Thompson to Company’s Board of Directors
6.4 Aug 23, 2017: Senior Novartis Executive Joins Proteus Digital Health as Chief Financial Officer
6.5 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.6 Aug 21, 2017: EnteroMedics Announces First Veterans Choice Program vBloc Implant at MedStar Health in Maryland
6.7 Aug 16, 2017: EnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual Conference
6.8 Aug 13, 2017: GI Dynamics Welcomes New Members to its Scientific Advisory Board
6.9 Aug 10, 2017: Apollo Endosurgery Provides Update And Clarity To FDA Letter To Health Care Providers Related To Potential Risks Of Intragastric Balloons
6.10 Aug 08, 2017: EnteroMedics Announces Second Quarter 2017 Financial Results
6.11 Aug 02, 2017: Obalon Announces Second Quarter 2017 Financial Results
6.12 Aug 01, 2017: Apollo Endosurgery Reports Second Quarter 2017 Results
6.13 Jul 31, 2017: EnteroMedics Receives Approval for Gastric Vest System Clinical Study in Spain
6.14 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.15 Jul 12, 2017: Gelesis Announces Last Patient Out in the Pivotal Gelesis100 Weight-Loss Study
6.16 Jul 12, 2017: Gelesis Announces Data on Gelesis200
6.17 Jul 12, 2017: Apollo Endosurgery Reports Preliminary Unaudited Financial Estimates for the Second Quarter of 2017
6.18 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
6.19 Jun 21, 2017: Aspire Bariatrics Announces AspireAssist Receives Australian TGA Approval and First Commercial Cases Performed in Australia
6.20 Jun 21, 2017: EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference
6.21 Jun 19, 2017: GI Dynamics Announces Additional Members to Its Scientific Advisory Board
6.22 Jun 11, 2017: First Data Derived from ABCD Worldwide EndoBarrier Registry Presented at ADA Shows Sustained Metabolic Improvements in Patients with Obesity and Type 2 Diabetes at Six Months Post-explant
6.23 Jun 02, 2017: GI Dynamics Announces Change to Board of Directors
6.24 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
6.25 May 19, 2017: Vizient Submits Comments to the FDA about Biosimilar Interchangeability, Looks Forward to Working toward Lowering Drug Costs
6.26 May 16, 2017: EnteroMedics Announces First Quarter 2017 Financial Results
6.27 May 11, 2017: Obalon Receives Regulatory Approvals to Commercialize in Select Middle East Markets
6.28 May 10, 2017: Obalon Announces First Quarter 2017 Financial Results
6.29 May 08, 2017: GI Dynamics Announces Scientific Advisory Board Members to Further Development of EndoBarrier
6.30 May 04, 2017: Apollo Endosurgery Reports First Quarter 2017 Results
6.31 May 03, 2017: GI Dynamics Announces EndoBarrier Data to be Presented at Digestive Disease Week
6.32 May 02, 2017: Apollo Endosurgery To Present Data on ORBERA Intragastric Balloon System at Digestive Disease Week 2017 Conference
6.33 Apr 28, 2017: Obalon Balloon System to be Included in Two Presentations at the Aesthetic Meeting 2017
6.34 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
6.35 Apr 25, 2017: BarioSurg Showcasing Its Next Generation Obesity Technology, the Gastric Vest System at the VII Medical Congress Angeles Group
6.36 Apr 23, 2017: Bard Announces First Quarter Results
6.37 Apr 03, 2017: Michigan Physician Successfully Performs First AspireAssist Non-Surgical Weight Loss Procedures In The State
6.38 Mar 28, 2017: Genesis Automation Awarded Group Purchasing Contract with Vizient To Provide Integrated Supply Chain Management Technology
6.39 Mar 15, 2017: David Moatazedi Joins Obalon Therapeutics Board of Directors
6.40 Mar 13, 2017: GI Dynamics Announces Scientific Advisory Board Members to Further Scientific Understanding of EndoBarrier
6.41 Mar 08, 2017: Apollo Endosurgery Reports Fourth Quarter and Full Year 2016 Results
6.42 Mar 07, 2017: GI Dynamics Announces New Scientific Advisory Board and Board’s First Two Members
6.43 Mar 07, 2017: EnteroMedics Reports Fourth Quarter 2016 Financial Results
6.44 Mar 06, 2017: TransEnterix Reports Operating Results for the Fourth Quarter and Full Year 2016
6.45 Mar 01, 2017: ZELTIQ Announces Fourth Quarter and Full Year 2016 Financial Results
6.46 Feb 23, 2017: Obalon Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results
6.47 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
6.48 Feb 09, 2017: EnteroMedics Announces Publication of Three-Year Data from vBloc Diabetic Patient Study in Journal of Diabetes and Obesity
6.49 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
6.50 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
6.51 Jan 31, 2017: GI Dynamics: Quarterly Report - Quarter Ended 31 December 2016
6.52 Jan 30, 2017: New Jersey Bariatric Center Performs First Obalon Gastric Balloon Procedure for Weight Loss in NJ
6.53 Jan 26, 2017: Bard Announces Fourth Quarter Results
6.54 Jan 25, 2017: BAROnova Announces Completion of ENDObesity II Pivotal Clinical Trial Enrollment
6.55 Jan 24, 2017: Mayo Clinic Selects Vizient as Its Performance Improvement Partner
6.56 Jan 18, 2017: FDA Approves Obalon Balloon System
6.57 Jan 17, 2017: Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer
6.58 Jan 17, 2017: Jonah Shacknai Joins Obalon Therapeutics Board of Directors
6.59 Jan 13, 2017: Obalon Announces Initial Commercial Patient Placements of the First and Only Swallowable, FDA-Approved Balloon System for Weight Loss
6.60 Jan 11, 2017: GI Dynamics Provides 2017 Business Outlook and 2016 Review
6.61 Jan 09, 2017: ZELTIQ Reports Preliminary Fourth Quarter and Full Year 2016 Revenue and Provides 2017 Guidance
6.62 Jan 09, 2017: ZELTIQ Aesthetics Announces Commercial Leadership Transition
6.63 Jan 05, 2017: Aspire Bariatrics Announces Two-Year Observational Study Results Published in BMC Obesity for AspireAssist
6.64 Jan 05, 2017: GI Dynamics Appoints Oern R. Stuge, MD, Amid Change to Company’s Board of Directors
6.65 Dec 14, 2016: BMI of Texas Selected as Exclusive Provider of Obalon System
6.66 Dec 06, 2016: AspireAssist Pivotal Trial Results Published in the American Journal of Gastroenterology
6.67 Dec 06, 2016: Dedicated to Innovation: Next-Generation Vanquish ME Device from BTL Aesthetics Reduces 53% More Fat Than its Predecessor
6.68 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
6.69 Nov 22, 2016: EnteroMedics Provides Commercialization and Corporate Update
6.70 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
6.71 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
6.72 Nov 11, 2016: Obalon Therapeutics Announces Third Quarter Financial Results
6.73 Nov 09, 2016: TransEnterix Reports Operating Results for the Third Quarter 2016
6.74 Nov 09, 2016: ZELTIQ Announces Third Quarter 2016 Financial Results
6.75 Nov 04, 2016: ReShape Medical Unveils US Commercial Data Demonstrating Increased Weight Loss with ReShape Dual Balloon
6.76 Nov 04, 2016: Obalon Announces Data Presentation at the Annual Meeting of the American Society for Metabolic and Bariatric Surgery
6.77 Nov 02, 2016: Apollo Endosurgery Announces Successful Completion of LAP-BAND FDA Post-Approval Study
6.78 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
6.79 Oct 25, 2016: Bard Announces Third Quarter Results
6.80 Oct 17, 2016: Freudenberg Medical Recognized at Medical Device Design Excellence Awards
6.81 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
6.82 Sep 28, 2016: New York Bariatric Group is the First Medical Practice in America Since FDA Approval to Perform Non Surgical Weight Loss Solution - AspireAssist
6.83 Sep 28, 2016: Vizient Launches Ediom, a Cognitive Computing and Data Science Company
6.84 Sep 27, 2016: EnteroMedics Announces Appointment of Dan Gladney as Chairman of the Board of Directors
6.85 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
6.86 Sep 12, 2016: Obalon Announces FDA Approval Of Obalon Balloon System
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Bariatric Surgery Devices - Pipeline Products by Stage of Development
Table 2: Bariatric Surgery Devices - Pipeline Products by Segment
Table 3: Bariatric Surgery Devices - Pipeline Products by Territory
Table 4: Bariatric Surgery Devices - Pipeline Products by Regulatory Path
Table 5: Bariatric Surgery Devices - Pipeline Products by Estimated Approval Date
Table 6: Bariatric Surgery Devices - Ongoing Clinical Trials
Table 7: Bariatric Surgery Devices Companies - Pipeline Products by Stage of Development
Table 8: Bariatric Surgery Devices - Pipeline Products by Stage of Development
Table 9: 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Gastric Sleeve Magnetic Implant - Product Status
Table 11: Gastric Sleeve Magnetic Implant - Product Description
Table 12: Allurion Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Elipse Balloon - Product Status
Table 14: Elipse Balloon - Product Description
Table 15: Allurion Technologies, Inc. - Ongoing Clinical Trials Overview
Table 16: Elipse Balloon - A Randomized, Multi-center, Phased, Pivotal Safety and Efficacy Study Comparing the Elipse Gastric Balloon System Versus Sham for the Treatment of Obese Adults
Table 17: Elipse Balloon - Pilot Trial of the Elipse Intragastric Balloon System for the Treatment of Overweight and Obese Individuals
Table 18: Apollo Endosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: ORBERA365 Managed Weight Loss System - Product Status
Table 20: ORBERA365 Managed Weight Loss System - Product Description
Table 21: Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Next Generation Bariatric Surgical Device - Product Status
Table 23: Next Generation Bariatric Surgical Device - Product Description
Table 24: BAROnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 25: TransPyloric Shuttle Device - Product Status
Table 26: TransPyloric Shuttle Device - Product Description
Table 27: BAROnova, Inc. - Ongoing Clinical Trials Overview
Table 28: TransPyloric Shuttle Device - Endoscopic Treatment for Weight Reduction in Patients with Obesity Using the TransPyloric Shuttle System: A Multicenter, Prospective, Randomized, Double-blind, Sham-controlled, Parallel-design Study
Table 29: BFKW, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Full Sense - Product Status
Table 31: Full Sense - Product Description
Table 32: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 33: TERIS - Product Status
Table 34: TERIS - Product Description
Table 35: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Restore Suturing System - Product Status
Table 37: Restore Suturing System - Product Description
Table 38: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Gastric Bypass Shunt - Product Status
Table 40: Gastric Bypass Shunt - Product Description
Table 41: Crospon Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 42: BaroFLIP System - Product Status
Table 43: BaroFLIP System - Product Description
Table 44: EndoRetics Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Endoretics Device - Product Status
Table 46: Endoretics Device - Product Description
Table 47: EndoVx Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: EndoVx Device - Product Status
Table 49: EndoVx Device - Product Description
Table 50: EnteroMedics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Gastric Vest System - Product Status
Table 52: Gastric Vest System - Product Description
Table 53: EnteroMedics Inc - Ongoing Clinical Trials Overview
Table 54: Gastric Vest System - Safety and Performance Study for the Gastric Vest System: CE Mark Study
Table 55: Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Gelesis100 - Product Status
Table 57: Gelesis100 - Product Description
Table 58: Gelesis100 Pediatric And Obese Overweight - Product Status
Table 59: Gelesis100 Pediatric And Obese Overweight - Product Description
Table 60: Gelesis100 Prediabetic And Diabetic Overweight - Product Status
Table 61: Gelesis100 Prediabetic And Diabetic Overweight - Product Description
Table 62: Gelesis200 - Product Status
Table 63: Gelesis200 - Product Description
Table 64: Gelesis Inc - Ongoing Clinical Trials Overview
Table 65: Gelesis100 - A Randomized, Double-blind, Placebo-controlled, Parallel-group Study Assessing the Effect of Gelesis100 on Body Weight in Overweight and Obese Subjects with and without Type 2 Diabetes
Table 66: Gelesis100 - An Open-label Study Assessing the Effect of Gelesis100 on Weight Loss and Weight Maintenance in Overweight and Obese Subjects Who Completed the GLOW Study (G-04)
Table 67: Gelesis200 - A Randomized, Double-blind, Placebo-controlled, Parallel-group Study Assessing the Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects with Prediabetes and Met Forming-treated Type 2 Diabetes
Table 68: Gelesis200 - A Randomized, Open-label, Crossover Study Assessing the Effects of Gelesis200 on Glucose and Insulin Following a Single Administration of Gelesis200 in Healthy Subjects
Table 69: GI Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 70: EndoBarrier Flow Restrictor - Product Status
Table 71: EndoBarrier Flow Restrictor - Product Description
Table 72: EndoBarrier Liner With EndoBarrier Restrictor - Product Status
Table 73: EndoBarrier Liner With EndoBarrier Restrictor - Product Description
Table 74: GI Dynamics Inc - Ongoing Clinical Trials Overview
Table 75: EndoBarrier Liner With EndoBarrier Restrictor - Endoscopic Treatment of Obesity with a Duodenal-jejunal Bypass Sleeve: Does Impairment of Fat Absorption Explain Weight Loss
Table 76: EndoBarrier Liner With EndoBarrier Restrictor - Randomisation to Endoluminal Intestinal Liner Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)
Table 77: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
Table 78: MetaboShield - Product Status
Table 79: MetaboShield - Product Description
Table 80: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Gastric Balloon - Product Status
Table 82: Gastric Balloon - Product Description
Table 83: Gastric Sleeve - Product Status
Table 84: Gastric Sleeve - Product Description
Table 85: Laparoscopic Band - Product Status
Table 86: Laparoscopic Band - Product Description
Table 87: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 88: Image-guided Bariatric Arterial Embolization Device - Product Status
Table 89: Image-guided Bariatric Arterial Embolization Device - Product Description
Table 90: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
Table 91: Endoscopic Therapy Device - Obesity - Product Status
Table 92: Endoscopic Therapy Device - Obesity - Product Description
Table 93: Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 94: Medi-Globe Gastric Balloon - Product Status
Table 95: Medi-Globe Gastric Balloon - Product Description
Table 96: MetaModix, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 97: Endosleeve - Product Status
Table 98: Endosleeve - Product Description
Table 99: Second Generation Liner Device - Product Status
Table 100: Second Generation Liner Device - Product Description
Table 101: Mmtc, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Wearable BAT Monitor - Product Status
Table 103: Wearable BAT Monitor - Product Description
Table 104: National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
Table 105: Weight Management Device - Product Status
Table 106: Weight Management Device - Product Description
Table 107: Precision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 108: Flow Control Device - Obesity - Product Status
Table 109: Flow Control Device - Obesity - Product Description
Table 110: Satiety Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 111: TOGA System - Product Status
Table 112: TOGA System - Product Description
Table 113: Satiety Inc - Ongoing Clinical Trials Overview
Table 114: TOGA System - Endoscopic Bariatric Stapling Pilot Study
Table 115: Sensate LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 116: Sensate Anchored Gastric Device - Product Status
Table 117: Sensate Anchored Gastric Device - Product Description
Table 118: Silhouette Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 119: nObese Device - Product Status
Table 120: nObese Device - Product Description
Table 121: SLIMEDICS LTD Pipeline Products & Ongoing Clinical Trials Overview
Table 122: Intra Gastric Implant - Product Status
Table 123: Intra Gastric Implant - Product Description
Table 124: Spatz FGIA, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 125: Spatz3 Adjustable Balloon System - Product Status
Table 126: Spatz3 Adjustable Balloon System - Product Description
Table 127: Standard Bariatrics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 128: Gastrectomy Stapling Guide - Product Status
Table 129: Gastrectomy Stapling Guide - Product Description
Table 130: Surefire Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 131: Surefire Infusion Catheter System - Obesity - Product Status
Table 132: Surefire Infusion Catheter System - Obesity - Product Description
Table 133: SynerZ Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 134: Aegis Device - Product Status
Table 135: Aegis Device - Product Description
Table 136: The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview
Table 137: Obesity Balloon - Product Status
Table 138: Obesity Balloon - Product Description
Table 139: TransEnterix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 140: Intraluminal Gastroplasty Device - Obesity - Product Status
Table 141: Intraluminal Gastroplasty Device - Obesity - Product Description
Table 142: Tulip Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 143: Tulip Capsule - Product Status
Table 144: Tulip Capsule - Product Description
Table 145: UAS LifeSciences LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 146: Ingestible Gastrointestinal Sampling Device - Product Status
Table 147: Ingestible Gastrointestinal Sampling Device - Product Description
Table 148: University of Florida Pipeline Products & Ongoing Clinical Trials Overview
Table 149: Mutated Gene Repair System - Product Status
Table 150: Mutated Gene Repair System - Product Description
Table 151: University of Miami Pipeline Products & Ongoing Clinical Trials Overview
Table 152: EEA Anvil Placement Device - Product Status
Table 153: EEA Anvil Placement Device - Product Description
Table 154: ValenTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 155: ValenTx Endoluminal Bypass System - Product Status
Table 156: ValenTx Endoluminal Bypass System - Product Description
Table 157: ValenTx, Inc. - Ongoing Clinical Trials Overview
Table 158: ValenTx Endoluminal Bypass System - An Open Label Trial of the Safety and Effectiveness of the ValenTx Endo Bypass System and Use of the Endoscopic Anchor Placement Device in Obese Subjects
Table 159: ValenTx Endoluminal Bypass System - Safety and Efficacy of the ValenTx EndoPass System for the Treatment of Obese Subjects: The ePass Clinical Trial
Table 160: Vancive Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview
Table 161: 7-Day Body Monitor Patch - Product Status
Table 162: 7-Day Body Monitor Patch - Product Description
Table 163: Vibrynt, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 164: PREVAIL Implant System - Product Status
Table 165: PREVAIL Implant System - Product Description
Table 166: Glossary

List of Figures
Figure 1: Bariatric Surgery Devices - Pipeline Products by Stage of Development
Figure 2: Bariatric Surgery Devices - Pipeline Products by Segment
Figure 3: Bariatric Surgery Devices - Pipeline Products by Territory
Figure 4: Bariatric Surgery Devices - Pipeline Products by Regulatory Path
Figure 5: Bariatric Surgery Devices - Pipeline Products by Estimated Approval Date
Figure 6: Bariatric Surgery Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3DT Holdings, LLC
  • Allurion Technologies, Inc.
  • Apollo Endosurgery Inc
  • Applied Medical Resources Corporation
  • BAROnova, Inc.
  • BFKW, LLC
  • Boston Scientific Corp
  • C. R. Bard Inc
  • Columbia University
  • Crospon Ltd
  • EndoRetics Inc.
  • EndoVx Inc
  • EnteroMedics Inc
  • Gelesis Inc
  • GI Dynamics Inc
  • Hebrew University of Jerusalem
  • Innovia LLC
  • John Hopkins University
  • Mayo Clinic US
  • Medi-Globe GmbH
  • MetaModix, Inc
  • Mmtc, Inc.
  • National University of Singapore
  • Precision Medical Devices, Inc.
  • Satiety Inc
  • Sensate LLC
  • Silhouette Medical, Inc.
  • SLIMEDICS LTD
  • Spatz FGIA, Inc
  • Standard Bariatrics, Inc.
  • Surefire Medical Inc
  • SynerZ Medical, Inc.
  • The Sheikh Zayed Institute for Pediatric Surgical Innovation
  • TransEnterix, Inc.
  • Tulip Medical Ltd.
  • UAS LifeSciences LLC
  • University of Florida
  • University of Miami
  • ValenTx, Inc.
  • Vancive Medical Technologies
  • Vibrynt, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll